Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research

Overview

Journal PLoS Med

Specialty General Medicine

Date 2013 Feb 9

PMID 23393429

Citations 293

Authors

Richard D Riley

Jill A Hayden

Ewout W Steyerberg

Karel G M Moons

Keith Abrams

Panayiotis A Kyzas

Nuria Malats

Andrew Briggs

Sara Schroter

Douglas G Altman

Harry Hemingway

Affiliations

Soon will be listed here.

Abstract

Prognostic factor research aims to identify factors associated with subsequent clinical outcome in people with a particular disease or health condition. In this article, the second in the PROGRESS series, the authors discuss the role of prognostic factors in current clinical practice, randomised trials, and developing new interventions, and explain why and how prognostic factor research should be improved.

Citing Articles

The revised Canadian Bleeding (CAN-BLEED) score for risk stratification of bleeding trauma patients: a mixed retrospective-prospective cohort study.

Tran A, Lamb T, Fernando S, Charette M, Nemnom M, Matar M Scand J Trauma Resusc Emerg Med. 2025; 33(1):31.

PMID: 39979932 PMC: 11844109. DOI: 10.1186/s13049-025-01336-z.

Using a Two-Steps Clustering and PCA Analysis for Stratified Chronic Non-Cancer Pain Care: A Retrospective Cross-Sectional Study.

Peiro A, Barrachina J, Escorial M, Aguado I, Margarit C, Grimby-Ekman A J Pain Res. 2025; 18:673-684.

PMID: 39958578 PMC: 11829594. DOI: 10.2147/JPR.S490442.

Exploring the value of routinely collected data on EQ-5D-5L and other electronic patient-reported outcome measures as prognostic factors in adults with advanced non-small cell lung cancer receiving immunotherapy.

Liao K, Wong D, Gomes F, Faivre-Finn C, Moliner L, Sperrin M BMJ Oncol. 2025; 3(1):e000158.

PMID: 39886146 PMC: 11203075. DOI: 10.1136/bmjonc-2023-000158.

A systematic review of passive data for remote monitoring in psychosis and schizophrenia.

Bladon S, Eisner E, Bucci S, Oluwatayo A, Martin G, Sperrin M NPJ Digit Med. 2025; 8(1):62.

PMID: 39870797 PMC: 11772847. DOI: 10.1038/s41746-025-01451-2.

Exploring CX3CR1 as a prognostic biomarker and immunotherapeutic target in sarcoma.

Li T, Li X, Kang P, Zhao J Transl Oncol. 2025; 53:102283.

PMID: 39837057 PMC: 11787715. DOI: 10.1016/j.tranon.2025.102283.

References

Maas A, Steyerberg E, Marmarou A, McHugh G, Lingsma H, Butcher I . IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics. 2010; 7(1):127-34. PMC: 5084119. DOI: 10.1016/j.nurt.2009.10.020. View

Steyerberg E, Mushkudiani N, Perel P, Butcher I, Lu J, McHugh G . Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med. 2008; 5(8):e165. PMC: 2494563. DOI: 10.1371/journal.pmed.0050165. View

Dupuy A, Simon R . Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst. 2007; 99(2):147-57. DOI: 10.1093/jnci/djk018. View

Hayden J, Chou R, Hogg-Johnson S, Bombardier C . Systematic reviews of low back pain prognosis had variable methods and results: guidance for future prognosis reviews. J Clin Epidemiol. 2009; 62(8):781-796.e1. DOI: 10.1016/j.jclinepi.2008.09.004. View

Royston P, Altman D, Sauerbrei W . Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2005; 25(1):127-41. DOI: 10.1002/sim.2331. View

Riley R, Lambert P, Abo-Zaid G . Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010; 340:c221. DOI: 10.1136/bmj.c221. View

Clay F, Newstead S, McClure R . A systematic review of early prognostic factors for return to work following acute orthopaedic trauma. Injury. 2010; 41(8):787-803. DOI: 10.1016/j.injury.2010.04.005. View

Altman D, Riley R . Primer: an evidence-based approach to prognostic markers. Nat Clin Pract Oncol. 2005; 2(9):466-72. DOI: 10.1038/ncponc0287. View

Maas A, Marmarou A, Murray G, Teasdale S, Steyerberg E . Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. J Neurotrauma. 2007; 24(2):232-8. DOI: 10.1089/neu.2006.0024. View

10.

Mostertz W, Stevenson M, Acharya C, Chan I, Walters K, Lamlertthon W . Age- and sex-specific genomic profiles in non-small cell lung cancer. JAMA. 2010; 303(6):535-43. DOI: 10.1001/jama.2010.80. View

11.

Simon R, Altman D . Statistical aspects of prognostic factor studies in oncology. Br J Cancer. 1994; 69(6):979-85. PMC: 1969431. DOI: 10.1038/bjc.1994.192. View

12.

Riley R, Abrams K, Sutton A, Lambert P, Jones D, Heney D . Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. Br J Cancer. 2003; 88(8):1191-8. PMC: 2747576. DOI: 10.1038/sj.bjc.6600886. View

13.

Riley R, Sauerbrei W, Altman D . Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond. Br J Cancer. 2009; 100(8):1219-29. PMC: 2676559. DOI: 10.1038/sj.bjc.6604999. View

14.

Roozenbeek B, Maas A, Lingsma H, Butcher I, Lu J, Marmarou A . Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?. Crit Care Med. 2009; 37(10):2683-90. DOI: 10.1097/ccm.0b013e3181ab85ec. View

15.

Kyzas P, Denaxa-Kyza D, Ioannidis J . Almost all articles on cancer prognostic markers report statistically significant results. Eur J Cancer. 2007; 43(17):2559-79. DOI: 10.1016/j.ejca.2007.08.030. View

16.

Abo-Zaid G, Sauerbrei W, Riley R . Individual participant data meta-analysis of prognostic factor studies: state of the art?. BMC Med Res Methodol. 2012; 12:56. PMC: 3413577. DOI: 10.1186/1471-2288-12-56. View

17.

Chou R, Shekelle P . Will this patient develop persistent disabling low back pain?. JAMA. 2010; 303(13):1295-302. DOI: 10.1001/jama.2010.344. View

18.

Kyzas P, Loizou K, Ioannidis J . Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst. 2005; 97(14):1043-55. DOI: 10.1093/jnci/dji184. View

19.

Renehan A, Egger M, Saunders M, ODwyer S . Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002; 324(7341):813. PMC: 100789. DOI: 10.1136/bmj.324.7341.813. View

20.

Altman D . Systematic reviews of evaluations of prognostic variables. BMJ. 2001; 323(7306):224-8. PMC: 1120839. DOI: 10.1136/bmj.323.7306.224. View